These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1754657)

  • 21. Measurement of depression and negative symptoms in schizophrenia.
    Goldman RS; Tandon R; Liberzon I; Greden JF
    Psychopathology; 1992; 25(1):49-56. PubMed ID: 1351305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind trial of thiothixene and chlorpromazine in acute schizophrenia.
    Rickels K; Byrdy H; Valentine J; Postel W; Norstad N; Downing R
    Int Pharmacopsychiatry; 1978; 13(1):50-7. PubMed ID: 342437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures.
    Hogan TP; Awad AG
    Psychol Med; 1992 May; 22(2):347-52. PubMed ID: 1615101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes.
    Arango C; Breier A; McMahon R; Carpenter WT; Buchanan RW
    Am J Psychiatry; 2003 Aug; 160(8):1421-7. PubMed ID: 12900303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of the efficacy of thiothixene and a chlorpromazine-imipramine combination for depression in schizophrenia.
    Becker RE
    Am J Psychiatry; 1983 Feb; 140(2):208-11. PubMed ID: 6336916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Total and free plasma neuroleptic levels in schizophrenic patients.
    Tang SW; Glaister J; Davidson L; Toth R; Jeffries JJ; Seeman P
    Psychiatry Res; 1984 Dec; 13(4):285-93. PubMed ID: 6596586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delusions and hallucinations in schizophrenic patients.
    de Leon J; Cuesta MJ; Peralta V
    Psychopathology; 1993; 26(5-6):286-91. PubMed ID: 8190849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response of negative symptoms of schizophrenia to neuroleptic treatment.
    Serban G; Siegel S; Gaffney M
    J Clin Psychiatry; 1992 Jul; 53(7):229-34. PubMed ID: 1639741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subsyndromes of chronic schizophrenia: a phenomenological study.
    Arora A; Avasthi A; Kulhara P
    Acta Psychiatr Scand; 1997 Sep; 96(3):225-9. PubMed ID: 9296554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability, and predictive validity.
    Bell M; Milstein R; Beam-Goulet J; Lysaker P; Cicchetti D
    J Nerv Ment Dis; 1992 Nov; 180(11):723-8. PubMed ID: 1431824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlates of rapid neuroleptic response in male patients with schizophrenia.
    Petrie EC; Faustman WO; Moses JA; Lombrozo L; Csernansky JG
    Psychiatry Res; 1990 Aug; 33(2):171-7. PubMed ID: 2243894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine.
    Tollefson GD; Sanger TM
    Am J Psychiatry; 1997 Apr; 154(4):466-74. PubMed ID: 9090332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dimensional and categorical approach to the symptomatology of recent-onset schizophrenia.
    Van der Does AJ; Linszen DH; Dingemans PM; Nugter MA; Scholte WF
    J Nerv Ment Dis; 1993 Dec; 181(12):744-9. PubMed ID: 8254326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The PANSS (Positive And Negative Symptom) Scale].
    Guelfi JD
    Encephale; 1997 Apr; 23 Spec No 2():35-8. PubMed ID: 9273305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The brief psychiatric rating scale: effect of scaling system on clinical response assessment.
    Thompson PA; Buckley PF; Meltzer HY
    J Clin Psychopharmacol; 1994 Oct; 14(5):344-6. PubMed ID: 7806691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The complex relationships between executive functions and positive symptoms in schizophrenia.
    Guillem F; Rinaldi M; Pampoulova T; Stip E
    Psychol Med; 2008 Jun; 38(6):853-60. PubMed ID: 18261245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lifelong course of positive and negative symptoms in chronically institutionalized patients with schizophrenia.
    Mancevski B; Keilp J; Kurzon M; Berman RM; Ortakov V; Harkavy-Friedman J; Rosoklija G; Dwork AJ
    Psychopathology; 2007; 40(2):83-92. PubMed ID: 17215594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
    Conley RR; Tamminga CA; Bartko JJ; Richardson C; Peszke M; Lingle J; Hegerty J; Love R; Gounaris C; Zaremba S
    Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive versus negative symptoms in schizophrenia: response to haloperidol.
    Palao DJ; Arauxo A; Brunet M; Marquez M; Bernardo M; Ferrer J; Gonzalez-Monclus E
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):155-64. PubMed ID: 8115670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haloperidol and reduced haloperidol concentrations in plasma and red blood cells from chronic schizophrenic patients.
    Ko GN; Korpi ER; Kirch DG
    J Clin Psychopharmacol; 1989 Jun; 9(3):186-90. PubMed ID: 2661607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.